A causal relationship between ammonia intoxication and hepatic coma is suggested by the reproduction of the syndrome of impending hepatic coma in sensitive patients with liver disease by substances from which ammonia can be derived (1) and is supported by demonstration of deranged ammonia metabolism in liver disease (2) . The frequent finding of elevated peripheral vein ammonia concentrations in hepatic coma (3) has encouraged incrimination of ammonia in the genesis of the syndrome (4, 5) . Conversely, reservations have been expressed that such results may signify no more than impaired nitrogen metabolism secondary to liver disease (6, 7) . More recently Bessman and Bessman (8) have questioned the validity of observations based on peripheral vein blood alone by demonstrating significant arterio-venous ammonia difference in hepatic coma. Moreover, a close relationship has been reported between arterial concentrations and neurological status in a patient with this complication (9) .
The purposes of this paper are: 1) Further assessment of the significance of arterial concentrations and A-V ammonia differences in hepatic coma, directing particular attention to the effect of eliminating from the diet nitrogenous substances from which ammonia may be derived; and 2) Investigation of a possible relationship between disordered ammonia metabolism and the elevated blood pyruvate and a-ketoglutarate concentrations reported in liver disease (10, 11) . Arterial concentration and tissue metabolism of ammonia have been compared with the neuropsychiatric state and with the protein intake in uncomplicated liver disease and hepatic coma. Simultaneous estimations of blood pyruvate and a-ketoglutarate were performed. The relationship of the keto-acids to ammonia metabolism was further studied in a smaller group of patients with liver disease by measuring blood concentrations of these substances in response to the administration of ammonium chloride.
MATERIAL AND METHODS
Patients. Twenty-seven patients (16 male and 11 female) in impending hepatic coma or coma were studied. Ages were distributed between 29 and 70 years. Twenty patients had cirrhosis associated with chronic alcoholism.
The etiology of cirrhosis was uncertain in three patients. One had arterial ammonia concentrations which were comparable in the early stages, but in patients who survived they returned towards normal more rapidly after protein withdrawal.
It was not possible to demonstrate a similar relationship between blood pyruvate or a-ketoglutarate concentrations and intake of nitrogenous material (Figure 3) . Mean values for both substances were high at all stages, particularly in patients who survived more than 10 days, but the scatter was wide.
Uptake of ammonia by peripheral tissue and brain Peripheral A-V ammonia difference in relation to arterial concentrations greater than 100 pg. per 100 ml. was compared in control subjects who had received ammonium chloride to patients with liver disease who also had received ammonium chloride or were in the early phase of impending hepatic coma (Figure 4 ). Although uptake of ammonia occurred in both groups, it was greater in control subjects in relation to arterial concentration and the impaired uptake in patients with liver disease was particularly striking at ammonia concentrations greater than 200 pug. per 100 ml. No difference was observed between patients with uncomplicated liver disease and those in impending hepatic coma.
Uptake of ammonia was the usual finding during the course of hepatic coma (Figures 1 and 3 (Table II) showed relatively small amounts of ammonia and a-ketoglutarate in control subjects, although py The mean elevation of blood a-ketoglutarate concentrations in patients with cirrhosis in response to ammonium chloride was less, but of a magnitude beyond the error of the method. It was a constant finding in every patient (Table   III) , and the greatest increase of a-ketoglutarate concentration occurred by 30 to 60 minutes, thus preceding the greatest alteration in pyruvate values.
Ammonia uptake by peripheral tissues following the administration of ammonium chloride was demonstrated by elevation of blood ammonia levels and positive A-V ammonia differences in both groups (Table III) , coinciding in patients with liver disease with elevation of a-ketoglutarate and preceding the major rise in pyruvate levels. The return to fasting values occurred earlier in patients receiving the drug intravenously, but further assessment of individual tolerance was not considered relevant to the study.
The sequence of events is demonstrated in Figure variably affected by fasting (17, 18) , but in our patients both arterial and venous values were normal under such circumstances. Impaired ammonia tolerance in liver disease (2), however, permits abnormal augmentations of blood ammonia following the ingestion of protein (19) , blood (20) , and other nitrogenous material (1). The highest ammonia concentrations in coma itself were also found by us to be related to these factors. During treatment with protein withdrawal and oral broad spectrum antibiotics, which presumably reduces the formation of ammonia and other toxic substances by suppression or change of intestinal flora (7, 21, 22) , arterial ammonia concentrations fell towards, but seldom to, normal. Simultaneously, clinical improvement often occurred and the decline in arterial ammonia values was earlier and greater in patients who subsequently recovered.
The finding of rising arterial ammonia concentrations later in the course of fatal cases, despite continued treatment and the absence of gastrointestinal bleeding or uremia, could only sometimes be related to release of ammonia from peripheral tissues or brain. Possible additional sources of ammonia include the kidneys, which function abnormally in hepatic coma (23) , and the failing liver, as high ammonia levels have been reported in renal and hepatic vein blood in hepatic coma (7, 16) . The parent compound is unknown and extensive investigation of the phenomenon of ammonia release from mouse brain failed to identify its origin (24, 25) . It is relevant, however, that Diamox* may liberate ammonia from the brain by direct inhibition of enzyme function, with elevation of arterial ammonia levels and the production of impending hepatic coma (18) , and it also releases ammonia from the kidney into the renal vein (26) .
The high incidence of elevated arterial ammonia concentrations in hepatic coma, with a terminal rise in fatal cases or a prompt fall on recovery, supports incrimination of ammonia intoxication in the genesis of the condition. However, the relationship between clinical status, arterial ammonia concentrations and ammonia uptake by brain and muscle reported by others (8, 9) is at variance with the frequently poor correlation in our patients. The occasional finding of normal values in coma also demands consideration.
Ammonia uptake by the brain, resulting in depletion of available a-ketoglutarate (27) , has been suggested as the basic disorder of cerebral metabolism in hepatic coma (8) , but our findings suggest that removal of ammonia may be accomplished without injury to the organism and that clinical deterioration is more readily related to failure of this removal system. Thus, although uptake of ammonia at the periphery occurred in the earlier stages of coma, the efficiency of this process was impaired relative to normal capacity, usually to an extent that could not be explained by increased blood flow in hepatic disease. Under these circumstances, progressive deterioration in ammonia removal would result in negligible uptake, equilibrium or even release of ammonia by peripheral tissues and brain, despite high arterial concentration. Such findings were, in fact, characteristic of the late stages of coma in our patients.
An increased metabolic load is thrown on brain, muscle and other tissues by the abnormal and prolonged rises in blood ammonia which follow absorption of ammonia from the portal vein in some patients with liver disease (2 (30) may be an additional factor. Biochemical interpretation of these changes is difficult as pyruvate and a-ketoglutarate may be involved simultaneously in more than one reaction.
The rise in pyruvate and a-ketoglutarate concentrations in response to ammonium chloride infusion in liver disease is compatible with a defect in intermediary metabolism (11) . It is therefore relevant that Amatuzio, Shrifter, Stutzman, and Nesbitt (31) demonstrated accumulation of blood pyruvate in response to glucose infusion in hepatic coma, a finding which would be in accord with inhibition of final glucose oxidation by the high blood ammonia content in this condition. The delayed fall in pyruvate values found in control subjects receiving ammonium chloride could result from utilization of pyruvate in the tissues for transamination reactions.
Additional biochemical findings in hepatic coma compatible with deranged ammonia metabolism include high blood concentrations of glutamine (32) , asparagine (33) , and other amino acids, all of which may reflect increased amidation and transamination involved in disposal of ammonia. Precise details of the metabolic disorder still remain uncertain and our investigation failed to support or exclude the theory of cerebral a-ketoglutarate depletion (8) . Augmentation rather than removal of peripheral blood a-ketoglutarate occurred in response to ammonium chloride administration in patients with liver disease and greatly increased amounts were available in the blood in hepatic coma. Nevertheless, the "blood-brain barrier" (34) may prevent replenishment of this keto-acid in the brain from peripheral blood (8) . Examination of the spinal fluid revealed comparatively small quantities of a-ketoglutarate, which is compatible with the hypothesis that it passes from blood to spinal fluid with difficulty, but the higher concentrations present in hepatic coma fail to exclude its availability to the brain.
Certain practical points are emphasized by this investigation. It was confirmed that similar clinical and biochemical abnormalities occur in hepatic coma regardless of the etiology of the liver disease or nature of the precipitating factor (7). Blood ammonia estimations, particularly arterial concentrations, may be of diagnostic assistance in the fasting patient, but the close relationship postulated between arterial values, tissue uptake of ammonia and clinical status (9) was unreliable be-cause blood ammonia concentrations reflect the amount of ammonia entering the circulation from the gastrointestinal tract and elsewhere, modified by release as well as uptake in various tissues, and the relationship between these factors is variable. The results of this investigation suggest the employment of antibiotics in treatment of hepatic coma (35) . Glutamic acid also reduces blood ammonia values (36, 37) and its variable effect as a therapeutic agent may in part be due to relative impotence in the presence of a large influx of ammonia in the non-protein-deprived patient or the transient nature of its action in severe liver disease (38) . On the other hand, its precursors, ammonia and a-ketoglutarate, were found in excess in peripheral blood in hepatic coma and elevated concentrations of glutamic acid itself have been reported in this condition (39) . It appears from these considerations that assessment of any agent in the therapy of hepatic coma should be compared with the effect of protein deprivation and include estimations of arterial ammonia concentrations while also taking into account the importance of nitrogenous material in the gastrointestinal tract. SUMMARY 1. In 27 patients studied in hepatic coma, blood ammonia concentrations were more frequently elevated in the artery than in the peripheral vein, but a good correlation with clinical status was evident at neither site. Fasting patients with uncomplicated liver disease had normal blood ammonia concentrations and the height of arterial values in hepatic coma was broadly related to the amount of nitrogenous material in the intestines. Values fell towards normal with protein withdrawal and broad spectrum antibiotic therapy, but a later elevation occurred in fatal cases, despite continuation of this regimen. The origin of this ammonia was uncertain and could only sometimes be attributed to release from brain or muscle.
2. Uptake of ammonia by peripheral tissues was impaired in liver disease relative to normal capacity. During the late stages of coma, poor uptake, equilibrium or release of ammonia by peripheral tissues or brain occurred, despite high arterial concentrations.
3. Elevation of blood pyruvate and a-ketoglutarate values paralleled the high blood ammonia concentration in hepatic coma. A rise in blood concentrations of these keto-acids followed the administration of ammonium chloride to patients with liver disease, but did not take place in control subjects. It is suggested that the high concentrations of keto-acids in hepatic coma represent a defect in intermediary metabolism due to impaired utilization of ammonia and faulty removal from the blood by a diseased liver. Concentrations of pyruvate in cerebro-spinal fluid were comparable to those in arterial blood, but relatively small amounts of a-ketoglutarate were found there, although values were above normal in hepatic coma.
4. The significance of blood ammonia concentrations in hepatic coma must take into account ammonia entering the system from the gastrointestinal tract, uptake or release of ammonia at various sites and the possibility of pre-existing defects in ammonia utilizing systems. Protein withdrawal with broad spectrum antibiotics effectively reduced blood ammonia values.
